Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Epimmune Inc. (NasdaqNM:EPMN)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials | Reports
Location
5820 Nancy Ridge Drive
San Diego, CA 92121
Phone: (858) 860-2500
Fax: (858) 860-2600
Employees (last reported count): 37
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 69%
·Institutional: 18% (57% of float)
(23 institutions)
·Net Inst. Buying: 148.0K shares (+7.68%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Epimmune Inc. is engaged in the development of novel vaccines for the treatment and prevention of infectious diseases and cancer. The Company is in preclinical development with therapeutic vaccines for breast, colon, lung and prostate cancers, hepatitis C, hepatitis B and HIV, and prophylactic vaccines for hepatitis C, HIV and malaria. The Company expects that a therapeutic vaccine targeting HIV will be the first of its candidate vaccines to enter human clinical trials. The Company expects initial clinical studies for this vaccine candidate to be initiated by late 2001 or early 2002.
More from Market Guide: Expanded Business Description

Financial Summary
Epimmune Inc., discovers, designs and develops new drugs for the effective treatment of acute and chronic inflammatory diseases, infectious diseases and cancer. For the six months ended 6/30/01, revenues rose from $691 thousand to $2.2 million. Net loss rose 4% to $2.3 million. Revenues reflect higher research and development contracts and license fees. Higher loss reflects increased R&D expenses due to higher costs for HIV grant program and related equipment and facility.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Howard Greene, Jr., 58
Chairman
--  
Emile Loria, M.D., 51
Pres, CEO, Director
--  
Robert De Vaere, 43
CFO, VP-Fin.
--  
Robert Chesnut, Ph.D., 57
Exec. VP, R&D and Sec.
$221K
Mark Newman, Ph.D., 46
VP, Infectious Disease Program
161K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:EPMNAs of 31-Aug-2001
Price and Volume
52-Week Low
on 22-Dec-2000
$1.594
Recent Price$3.40 
52-Week High
on 17-Jan-2001
$7.00 
Beta0.65 
Daily Volume (3-month avg)13.5K
Daily Volume (10-day avg)10.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-39.6%
52-Week Change
relative to S&P500
-18.9%
Share-Related Items
Market Capitalization$34.2M
Shares Outstanding10.1M
Float3.10M
Dividends & Splits
Annual Dividendnone 
Last Split: 1 for 7 on 16-Nov-1998
Per-Share Data
Book Value (mrq)$1.12 
Earnings (ttm)-$0.64 
Earnings (mrq)-$0.10 
Sales (ttm)$0.42 
Cash (mrq)$0.76 
Valuation Ratios
Price/Book (mrq)3.04 
Price/EarningsN/A 
Price/Sales (ttm)8.16 
Income Statements
Sales (ttm)$3.15M
EBITDA (ttm)-$5.17M
Income available to common (ttm)-$4.83M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-35.94%
Return on Equity (ttm)-42.76%
Financial Strength
Current Ratio (mrq)4.51 
Debt/Equity (mrq)0.06 
Total Cash (mrq)$6.72M
Short Interest
As of 8-Aug-2001
Shares Short78.0K
Percent of Float2.5%
Shares Short
(Prior Month)
80.0K
Short Ratio9.75 
Daily Volume8,000 
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.